vialauditThe Roundup

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

COMPOUNDING PHARMACY·PUBLIC-DATA TIER·LAST AUDITED 2026-05-29

Is Henry Meds legit?

Henry Meds is operating and surfaces credible public signals (composite 62/100), but we have not placed a first-hand consult yet — this is a public-data audit. Major private 503A telehealth compounder with a simpler "no insurance, no waiting rooms" pricing structure than Hims and a stronger buyer-experience signal across Trustpilot. Sits on the same post-shortage personalization-pathway regulatory pressure point that defines the cohort. The signal table below shows what we verified and what is still open. Read the full audit for FDA history, state-board records, and licensure footprint.

PREVIEW · NO TEST ORDER YET62/100 COMPOSITE

Signal table

WHAT WE VERIFIED
Status
Active
Model type
hybrid
Audit tier
public-data only
Composite score
62/100· PREVIEW — synthesized from public signals, first-hand consult pending
States served
all 50 states
PCAB accredited
No / not on file
FDA actions on record
None on record
State-board actions
None on record
Trustpilot
4.6/5 · 9,500 reviews· checked 2026-05-29
Last audited
2026-05-29

What works, what does not

AUDIT SUMMARY
+ STRENGTHS
  • No insurance / no waiting rooms cash-pay model with monthly pricing posted directly on the site (no quote-walls)
  • Telehealth platform is operationally mature with multi-vertical coverage (GLP-1 weight management, women's HRT, testosterone, ED, phentermine)
  • Trustpilot rating sits in the high-4 band, materially above the publicly-traded competitor Hims
  • Affiliated dispensing pharmacies in the network are FDA-registered 503A facilities under state-pharmacy-board oversight
  • Broad state licensure coverage - the platform ships to most US states through its affiliated pharmacy network
  • No reported Novo Nordisk public-dispute history (the post-shortage friction Hims experienced has not surfaced for Henry Meds publicly)
− WEAKNESSES
  • The "personalized" compounding pathway Henry Meds operates under after the 2025 shortage discretion closed is an active regulatory pressure point, identical to the cloud over Hims and the rest of the post-shortage cohort. FDA has stated personalization must be tied to documented clinical need, not used as a marketing pathway around the shortage rule
  • Private company - no SEC disclosure regime, no audited quarterly financials, no earnings-call transcripts. Verifiable record is thinner than Hims's
  • The per-fill dispensing pharmacy is not disclosed at checkout - a buyer does not know which 503A facility will fill their specific prescription
  • API (active pharmaceutical ingredient) sourcing dossier is not publicly disclosed at the upstream-manufacturer level
  • Subscription-model friction (cancellation, refill cadence) shows up in r/Tirzepatidecompound discussion alongside the same patterns we see for Hims
  • Named prescriber identity, NPI, and per-state medical licensure are not surfaced on the public site

What we mean by “legit”

SCORING SPINE

For a 503A compounding pharmacy, "legit" is not a single yes-or-no signal. The composite is a weighted average across nine dimensions — state pharmacy licensure footprint, FDA inspection history, state-board enforcement, USP <797> sterility signals, prescriber quality, raw-material sourcing, price transparency, buyer experience, and buyer protection. Read the full rubric at /methodology/compounding.

For Henry Meds the audit is "public-data tier" — we aggregate pharmacy disclosures, FDA databases, state-board records, NPI registry data, and community signals. A first-hand consult is pending and this page will be upgraded when that lands.

Frequently asked

6 QUESTIONS
Is Henry Meds legit?

Henry Meds is operating and surfaces credible public signals (composite 62/100), but we have not placed a first-hand consult yet — this is a public-data audit. Major private 503A telehealth compounder with a simpler "no insurance, no waiting rooms" pricing structure than Hims and a stronger buyer-experience signal across Trustpilot. Sits on the same post-shortage personalization-pathway regulatory pressure point that defines the cohort. The signal table below shows what we verified and what is still open. Read the full audit for FDA history, state-board records, and licensure footprint.

Is Henry Meds a real pharmacy?

Henry Meds operates a hybrid model — it both dispenses directly and routes some prescriptions to partner pharmacies. The legal entity is Henry Meds, Inc..

What states is Henry Meds licensed in?

Henry Meds serves all 50 states. You can confirm any state's licensure directly through that state's Board of Pharmacy license-lookup tool.

Has Henry Meds had any FDA inspections?

No FDA actions are on record (public databases as of 2026-05-29) for Henry Meds. Absence of a 483 or warning letter is not the same as a sterility audit — the FDA inspects 503A pharmacies on a complaint-driven and risk-based cycle, not annually.

Has vialaudit placed a consult with Henry Meds?

Not yet. Henry Meds is currently a public-data audit. We aggregate pharmacy disclosures, FDA inspection databases, state-board enforcement records, NPI registry data, and community signals. A first-hand consult is pending — this page upgrades when that lands.

How does Henry Meds compare to other compounding pharmacies?

Henry Meds's composite is 62/100. The composite is weighted across nine dimensions — licensure, FDA history, state enforcement, sterility, prescriber, sourcing, price transparency, buyer experience, and buyer protection. See /pharmacies for the full leaderboard and /methodology/compounding for the rubric.

Other audited pharmacies

IS IT LEGIT?

Sources

8 CITED
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH